BTI — biOasis Technologies Income Statement
0.000.00%
Last trade - 00:00- CA$0.40m
- CA$2.45m
- CA$0.04m
Annual income statement for biOasis Technologies, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2018 February 28th | 2019 February 28th | 2020 February 29th | C2021 February 28th | 2022 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.59 | 1.42 | 0.606 | 4.08 | 0.038 |
| Cost of Revenue | |||||
| Gross Profit | 0.122 | 1.41 | 0.606 | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5.87 | 6.28 | 5.21 | 4.09 | 3.62 |
| Operating Profit | -5.28 | -4.86 | -4.6 | -0.008 | -3.58 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -5.31 | -3.47 | -4.06 | 0.698 | -2.96 |
| Net Income After Taxes | -5.31 | -3.47 | -4.06 | 0.698 | -2.96 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.31 | -3.47 | -4.06 | 0.698 | -2.96 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.31 | -3.47 | -4.06 | 0.698 | -2.96 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.104 | -0.068 | -0.065 | -0.007 | -0.041 |